0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query gbi research breast cancer therapeutics asia pacific markets 2021 growth driven increasing uptake.Your search for "" gave back 1529091 results.
Myc Proto Oncogene Protein - Pipeline Review, H2 2020 Summary Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Toll Like Receptor 3 (CD283 or TLR3) - Drugs in Development, 2021 Summary Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Market Analysis and Insights: Global CDK4 & 6 Inhibitors for Breast Cancer Market The global CDK4 & 6 Inhibitors for Breast Cancer market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Globally Pharmaceutical markets are showing rapid growth and in coming years expected to evolve further in the field of research and development,...
Catalog:
IQ4I
May 2021
Price: USD 4,950.00
The global Breast Cancer Immunotherapy market is projected to reach US$ 60140 million in 2029, increasing from US$ 22610 million in 2022, with the...
Catalog:
MRRPB5
August 2023
Price: USD 2,900.00
Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Drugs in Development, 2021 Summary Cell Division Cycle 7 Related Protein Kinase...
Catalog:
Global Markets Direct
November 2021
Price: USD 3,500.00
Noninvasive Cancer Diagnostics Technology is a process for the detection of disease through minimal incisions into the body. Noninvasive cancer...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Heparanase - Drugs In Development, 2021 Summary Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
C-X-C Chemokine Receptor Type 2 - Pipeline Review, H2 2019 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity...
Catalog:
Global Markets Direct
November 2019
Price: USD 3,500.00
HR+/HER2-Breast Cancer Highlights The global HR+HER2- Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Highlights The global CDK4 & 6 Inhibitors for Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Histone Deacetylase 6 - Pipeline Review, H2 2019 Summary Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98)...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
